Treatment for Gallstones

Stanford University Medical Center, Stanford, CA
All Sexes

Study Summary

This trial found that using the SpyGlass™ system to directly view and remove biliary stones was as effective as the standard method of using a fluoroscope to guide a catheter through the biliary ducts.

Eligible Conditions
  • Gallstones

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 2 years

2 years
Adverse event evaluation
Complete stone clearance
Duration of Procedure
Radiation Exposure

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

0 Treatment Group

297 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

Boston Scientific CorporationLead Sponsor
687 Previous Clinical Trials
924,300 Total Patients Enrolled
3 Trials studying Gallstones
291 Patients Enrolled for Gallstones
Subhash Banerjee, MDPrincipal InvestigatorStanford University
18 Previous Clinical Trials
4,018,214 Total Patients Enrolled
Nirav Thosani, MDPrincipal InvestigatorUniveristy of Texas Health Sciences
1 Previous Clinical Trials
Raj J Shah, MDPrincipal InvestigatorUniversity of Colorado, Denver
2 Previous Clinical Trials
650 Total Patients Enrolled
Mohan Ramchandani, MDPrincipal InvestigatorAsian Institure of Gastroenterology
Guido Costamagna, MDPrincipal InvestigatorFundazione Policlinico Universitario
4 Previous Clinical Trials
1,796 Total Patients Enrolled
Rungsun Rerknimitr, MDPrincipal InvestigatorKing Chulalongkorn Memorial Hospital
1 Previous Clinical Trials
205 Total Patients Enrolled
Janak N Shah, MDPrincipal InvestigatorOchsner Health System
Mahesh Goenka, MDPrincipal InvestigatorApollo Gleneagles Hospitals, Kolkata

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have ongoing abdominal pain that may be caused by gallstones blocking the bile duct and you may need a procedure within 72 hours to remove them.
If the doctor thinks you might have kidney stones based on certain criteria, they may use a standard imaging test such as an abdominal ultrasound to confirm.

Frequently Asked Questions

Are there vacancies available for aspiring participants of this clinical experiment?

"The information on indicates that this medical investigation is still open for recruitment; it was publicly announced in September 2018, and the details were last refreshed on November 28th 2022." - Anonymous Online Contributor

Unverified Answer

How many physical sites are currently offering this research?

"Presently, this clinical trial is taking place at 4 sites: Houston, Stanford and Aurora being some of the notable locations. To help ease travel burdens for participants it is recommended to pick a centre close by when enrolling." - Anonymous Online Contributor

Unverified Answer

How many individuals are actively participating in this clinical experiment?

"This medical trial requires 297 participants, who meet the designated eligibility criteria. There are many potential sites for enrolment such as Ertan Digestive Disease Center - University of Texas Health Science Center in Houston and Stanford University Medical Center in Stanford." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.